Advertisement

Advertisement

MDCX Stock Latest News

Medicus Pharma Seeks Partner-Ready FDA Pathway for Prostate Cancer Drug Teverelix

Company AnnouncementsMedicus Pharma Seeks Partner-Ready FDA Pathway for Prostate Cancer Drug Teverelix

Medicus Pharma submits optimized Teverelix registrational protocol to FDA

PremiumThe Fly

Medicus Pharma submits optimized Teverelix registrational protocol to FDA

6d ago

Medicus Pharma Narrows SkinJect Development to Gorlin Syndrome in Capital-Efficient Shift

PremiumCompany Announcements

Medicus Pharma Narrows SkinJect Development to Gorlin Syndrome in Capital-Efficient Shift

14d ago

Medicus to focus future clinical development of SkinJect on Gorlin syndrome

PremiumThe Fly

Medicus to focus future clinical development of SkinJect on Gorlin syndrome

14d ago

Medicus Pharma Ends Standby Equity Purchase Agreement

PremiumCompany Announcements

Medicus Pharma Ends Standby Equity Purchase Agreement

21d ago

Medicus Pharma price target raised to $1 from 90c at Alliance Global

PremiumThe FlyMedicus Pharma price target raised to $1 from 90c at Alliance Global

21d ago

Medicus Pharma Announces Equity-Based Bonus Share Issuance

Company Announcements

Medicus Pharma Announces Equity-Based Bonus Share Issuance

24d ago

Medicus Pharma Sharpened Strategy Centers on Precision Oncology and Targeted Rare Disease Programs

Company Announcements

Medicus Pharma Sharpened Strategy Centers on Precision Oncology and Targeted Rare Disease Programs

27d ago

Medicus Pharma Secures Global Pfizer License for CD228V

PremiumCompany Announcements

Medicus Pharma Secures Global Pfizer License for CD228V

1M ago

Medicus Pharma price target lowered to 90c from $1 at Alliance Global

PremiumThe Fly

Medicus Pharma price target lowered to 90c from $1 at Alliance Global

2M ago

Medicus Pharma reports Q2 EPS (21c) vs (43c) last year

PremiumThe Fly

Medicus Pharma reports Q2 EPS (21c) vs (43c) last year

2M ago

Medicus Pharma Advances SkinJect and Teverelix Amid Financing Gains and Going-Concern Risk

PremiumCompany Announcements

Medicus Pharma Advances SkinJect and Teverelix Amid Financing Gains and Going-Concern Risk

2M ago

Medicus Pharma Teverelix granted investigational new drug authorization in UAE

PremiumThe FlyMedicus Pharma Teverelix granted investigational new drug authorization in UAE

2M ago

Medicus Pharma initiated with a Buy at Alliance Global

The Fly

Medicus Pharma initiated with a Buy at Alliance Global

2M ago

Medicus Pharma gets FDA green light for SkinJect Phase 2b Gorlin study

The Fly

Medicus Pharma gets FDA green light for SkinJect Phase 2b Gorlin study

2M ago

Medicus Pharma receives FDA feedback, IRB approval for Teverelix study

PremiumThe Fly

Medicus Pharma receives FDA feedback, IRB approval for Teverelix study

3M ago

Medicus submits SkinJect Rare Pediatric Disease Designation request to FDA

PremiumThe Fly

Medicus submits SkinJect Rare Pediatric Disease Designation request to FDA

4M ago

Medicus Pharma submits substantial modification application through EU CTIS

PremiumThe Fly

Medicus Pharma submits substantial modification application through EU CTIS

4M ago

Medicus Pharma Shareholders Approve Auditor, Board and Consolidation

PremiumCompany Announcements

Medicus Pharma Shareholders Approve Auditor, Board and Consolidation

4M ago

Medicus Pharma submits Protocol SKNJCT-005 to the FDA

PremiumThe FlyMedicus Pharma submits Protocol SKNJCT-005 to the FDA

4M ago

Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure

Company Announcements

Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure

4M ago

Medicus Pharma reports Q1 EPS (31c), consensus (22c)

The Fly

Medicus Pharma reports Q1 EPS (31c), consensus (22c)

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >